Abstract:Background: Disturbed endothelial barrier function is a hallmark of inflammation. Effusion of protein rich plasma fluid leading to edema formation and overshooting transmigration of leukocytes contribute to severe organ dysfunction under conditions of generalized inflammation, e.g. acute lung injury and sepsis. The peptide hormone Adrenomedullin (ADM) and its receptor (CRLR/RAMP2/3) constitute an important signaling system for the protection of endothelial barrier function. Although elevation of cAMP in endothelial cells was identified as signaling pathway of ADM responsible for barrier protection, it was speculated that other mechanisms are involved and precise intracellular signaling routes have not been explored, yet. Main findings and conclusions: ADM was confirmed to be a strong stabilizer of the endothelial barrier function in vitro, preventing and reversing hyperpermeability independent of the inflammatory stimulus (as determined by electrical impedance and FITC-dextran permeability measurements after stimulation with thrombin, TNFα, histamine, VEGF). Moreover, it was shown for the first time that ADM inhibited TNFα-induced granulocyte transmigration which was solely due to effects of ADM on endothelial cells. These in vitro-findings could be translated to animal models of vascular permeability and inflammation: ADM dose-dependently reduced vascular permeability in the skin of mice and rats (Miles assay; stimulus histamine). In a murine lipopolysaccharide (LPS)-induced lung injury model, ADM reduced lung edema and leukocyte extravasation. In endothelial cells, barrier protection could solely be reduced to cAMP signaling via the protein kinase A (PKA) and Epac-Rap1 pathways (dose response comparison with Forskolin). Dissection of the downstream cascade by means of cAMP analogs, specific for PKA and Epac-Rap1 signaling (benz-cAMP and “007”, respectively), demonstrated that both pathways are with respect to their efficacy equally involved in effects on permeability probably addressing independent effector mechanisms as suggested by enhanced efficacy of combination of both. Consistently, both pathway activators prevented vascular hyper-permeability in vivo. PKA activation and inhibition of MLC phosphorylation downstream of ADM diminish stimulus induced actin stressfiber formation and contraction of endothelial cells thus counteracting intercellular gap formation and hyperpermeability. Most notably, also effects independent of the contractile apparatus were demonstrated: ADM stabilized barrier function even in the absence of a functional actin cytosceletton after treatment with Cytochalasin D and knockdown of cortactin. ADM induced stabilization of VE-cadherin at the cell borders and increased the amount of detectable VE-cadherin/VE-PTP complex which is important for the regular function of VE-cadherin. In contrast, granulocyte transmigration was only reduced by PKA activation and ADM effects were lost after knockdown of cortactin. In line with this finding, a PKA inhibitor abolished the effect of ADM. As PKA activation reduces myosin light chain phosphorylation these data collectively link leukocyte extravasation to the contractile apparatus of the endothelial cell. As “007” was fully active with respect to TNFα induced hyperpermeability but had no effect with respect to granulocyte transmigration, endothelial hyperpermeability per se is not a prerequisite for granulocyte transmigration.

The role of cAMP signaling in the regulation of interleukin-33 production by RAW264.7 macrophages in response to various doses of lipopolysaccharide

IgG Immune Complex-Induced Acute Lung Injury is Ameliorated by Camp Via Down-Regulation of C/EBP- and AP-1-mediated Transcriptions.

Activation of Epac Alleviates Inflammation and Vascular Leakage in LPS-induced Acute Murine Lung Injury.

Inducible Microrna-223 Down-Regulation Promotes Tlr-Triggered Il-6 And Il-1 Beta Production In Macrophages By Targeting Stat3

Catecholamines Attenuate LPS-Induced Inflammation through β2 Adrenergic Receptor Activation- and PKA Phosphorylation-Mediated TLR4 Downregulation in Macrophages

Peucedanum Praeruptorum Dunn Polysaccharides Regulate Macrophage Inflammatory Response Through TLR2/TLR4-mediated MAPK and NF-κB Pathways.

Activation of RAW264.7 Macrophages by the Polysaccharide from the Roots of Actinidia Eriantha and Its Molecular Mechanisms.

A CRTH2 Antagonist, CT-133, Suppresses NF-κB Signalling to Relieve Lipopolysaccharide-Induced Acute Lung Injury.

Role of AMP-activated Protein Kinase in Regulating LPS-induced Secretion of Inflammatory Cytokines in Mouse Alveolar Macrophages

Diversity of Porphyromonad Gingivalis Lipopolysaccharide Induced IL-1β, TNF-α and IL-6 Levels in HL-60 Cells and the Associated Toll-like Receptors and Signaling Pathways

The Role of IL-33 on LPS-Induced Acute Lung Injury in Mice

Adenosine 5′-Monophosphate–Activated Protein Kinase Regulates IL-10–Mediated Anti-Inflammatory Signaling Pathways in Macrophages

Common and distinct signalling cascades in the production of tumour necrosis factor-alpha and interleukin-13 induced by lipopolysaccharide in RBL-2H3 cells

NFkB activation and cytokine output in LPS‐treated RAW 264.7 macrophages

Molecular Mechanisms Associated with Macrophage Activation by Rhizoma Atractylodis Macrocephalae Polysaccharides.

Macrophage Inflammatory Protein-2 in High Mobility Group Box 1 Secretion of Macrophage Cells Exposed to Lipopolysaccharide.

Forskolin-mediated cAMP activation upregulates TNF-α expression despite NF-κB downregulation in LPS-treated Schwann cells

Proteomic Dissection of Agonist-Specific TLR-Mediated Inflammatory Responses on Macrophages at Subcellular Resolution

C3a modulates IL-1β secretion in human monocytes by regulating ATP efflux and subsequent NLRP3 inflammasome activation

Ginsenoside Rg1 regulates innate immune responses in macrophages through differentially modulating the NF-κB and PI3K/Akt/mTOR pathways

Cellular signalling of adrenomedullin regulating endothelial barrier function and granulocyte extravasation